What this means
Aging is associated with a progressive loss of proteostasis and increased susceptibility to neurodegenerative and metabolic disorders. Among the molecular mechanisms implicated in these processes, protein persulfidation, a hydrogen sulfide (H2S)-mediated cysteine modification, has emerged as a critical regulator of protein function and redox homeostasis.
A plain-English summary is on its way. Until then, this is the start of the authors' own summary.
- Who it was tested in
- Earlier studies
- Kind of research
- A summary of earlier studies
The science
- Original title
- Targeting of Protein Persulfidation in Aging and Age-Related Disorders.
- Authors
- Hugo M, Garcia-Pardo J
- Journal
- Pharmaceutics
- Published
- Oct 27, 2026
- Study type
- Review
- PMID
- 42942798 ↗
Abstract
Aging is associated with a progressive loss of proteostasis and increased susceptibility to neurodegenerative and metabolic disorders. Among the molecular mechanisms implicated in these processes, protein persulfidation, a hydrogen sulfide (H2S)-mediated cysteine modification, has emerged as a critical regulator of protein function and redox homeostasis. Recent studies demonstrate that aging is accompanied by a decline in persulfidation and a concomitant increase in irreversible cysteine hyperoxidation, leading to protein dysfunction and aggregation. Beyond its established role in protecting proteins from oxidative damage, persulfidation has recently been shown to regulate biomolecular condensation and liquid-liquid phase separation, suppressing the formation of pathological protein assemblies linked to aging and neurodegenerative diseases. Moreover, pharmacological approaches that enhance persulfidation, including stimulation of endogenous H2S production and treatment with ergothioneine, improve metabolic resilience, increase NAD+ levels, and promote healthspan in experimental models. In this review, we discuss emerging evidence linking loss of persulfidation to protein aggregation, biomolecular condensates, and age-related functional decline, and highlight therapeutic strategies aimed at restoring persulfidation as a promising avenue for healthy aging and disease intervention.
Hugo M, Garcia-Pardo J Targeting of Protein Persulfidation in Aging and Age-Related Disorders. Pharmaceutics. 2026. doi:10.3390/pharmaceutics18101266. PMID: 42942798. https://pubmed.ncbi.nlm.nih.gov/42942798/
Related research
Two drugs together eased stroke brain damage in mice
Researchers gave mice two compounds, alone and together, after a stroke-like injury to the brain. The mice given both had less brain damage and better nerve function than those given either one alone.
Mitochondrial Quality Control in Degenerative Musculoskeletal Diseases: Signaling Networks and Therapeutic Landscapes.
Degenerative musculoskeletal disorders, including osteoarthritis (OA), intervertebral disc degeneration (IVDD), and osteoporosis (OP), are increasingly viewed as disorders of mitochondrial quality control (MQC) rather…
Eye supplements that target aging pathways: a review of current evidence
This review looked at vitamins and similar products for eye diseases tied to aging. It says early signs look promising, but long-term benefit is not yet proven.
SIRT1-Redox Crosstalk in Aging: Adaptive Capacity and Cellular State Transitions.
Aging gradually reduces the ability of cells to maintain and restore homeostasis under metabolic and oxidative stress.
Nicotinamide Mononucleotide-Producing Probiotic Strain B12-N Attenuates Aging and Cognitive Decline in a Caenorhabditis elegans Model of Alzheimer's Disease:…
Nicotinamide mononucleotide (NMN) is an active component found in probiotics that may help alleviate Alzheimer's disease and the effects of aging.
Sirtuin-1 in Hypertension: Linking Oxidative Stress and Mitochondrial Dysfunction to Vascular Aging and Therapeutic Potential.
Hypertension is a multifactorial cardiovascular disorder characterized by oxidative stress, endothelial dysfunction, chronic inflammation, mitochondrial impairment, and accelerated vascular aging, all of which…
See all research on NAD+ boosters →